• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Quantum BioPharma

< Previous 1 2 Next >
News headline image
Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)
December 23, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
December 22, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
December 19, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC
December 01, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
REPEAT: Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada’s Largest Banks, CIBC and RBC
November 28, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada’s Largest Banks, CIBC and RBC
November 27, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5
November 26, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum Biopharma’s USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5
November 25, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern’ Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio
November 07, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication
October 23, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend
October 20, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum BioPharma Ltd. Responds to Vague and Misleading Allegations by The Schall Law Firm and DJS Law Group
October 14, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock
October 08, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case
October 03, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial
October 02, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials
October 01, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders
September 29, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar and Q&A Session on Wednesday, October 1, 2025
September 24, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Health Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity™, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive Performance
September 18, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT
September 12, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target
September 10, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum BioPharma Announces Corporate Updates
August 21, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial
August 11, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients
August 08, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of
August 07, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)
August 05, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing
August 04, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO
July 31, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
News headline image
Quantum BioPharma Makes Strategic Investment in GameStop Corp.
July 22, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM GME QNTM
News headline image
Quantum BioPharma Submits its Candidate Breakthrough Patented Drug for Multiple Sclerosis for Fast-Track Program in the United Kingdom
July 08, 2025
From Quantum BioPharma
Via GlobeNewswire
Tickers CSE:QNTM QNTM
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap